2-メトキシ-5-[2-[[2-(2-エトキシフェノキシ)エチル]アミノ]プロピル]ベンゼンスルホンアミド·塩酸塩(80223-99-0)

ChemicalBook Optimization Suppliers
名前: J & K SCIENTIFIC LTD.  
電話番号: 010-82848833 400-666-7788
電子メール: jkinfo@jkchemical.com
名前: Chemsky(shanghai)International Co.,Ltd.  
電話番号: 021-50135380
電子メール: shchemsky@sina.com
名前: Sinopharm Chemical Reagent Co,Ltd.  
電話番号: 86-21-63210123
電子メール: sj_scrc@sinopharm.com
名前: Nanjing Sunlida Biological Technology Co., Ltd.  
電話番号: 025-57798810
電子メール: sales@sunlidabio.com
名前: Jinan Mingya Medical Technology Co., Ltd.  
電話番号: 0531-85828981
電子メール: 864598798@qq.com
2-メトキシ-5-[2-[[2-(2-エトキシフェノキシ)エチル]アミノ]プロピル]ベンゼンスルホンアミド·塩酸塩 製品概要
化学名:2-メトキシ-5-[2-[[2-(2-エトキシフェノキシ)エチル]アミノ]プロピル]ベンゼンスルホンアミド·塩酸塩
英語化学名:Tamsulosin hydrochloride
别名:Tamsulosinehydrochloride;Benzenesulfonamide, 5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-, monohydrochloride (9CI);dl-Tamsulosin hydrochloride;(-)-(R)-5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide hydrochloride;Tamsulosin hydrochloride;Tamuzosin hydrochloride;EC-617;Racemic Tamsulosin Hydrochloride (50 mg)
CAS番号:80223-99-0
分子式:C20H29ClN2O5S
分子量:444.97
EINECS:
カテゴリ情報:Intermediates & Fine Chemicals;Isotope Labelled Compounds;Pharmaceuticals
Mol File:80223-99-0.mol
2-メトキシ-5-[2-[[2-(2-エトキシフェノキシ)エチル]アミノ]プロピル]ベンゼンスルホンアミド·塩酸塩
2-メトキシ-5-[2-[[2-(2-エトキシフェノキシ)エチル]アミノ]プロピル]ベンゼンスルホンアミド·塩酸塩 物理性質
融点 254-256 °C
溶解性DMSO (Slightly), Methanol (Slightly), Water (Slightly)
安全性情報
HSコード 2935909550
MSDS Information
2-メトキシ-5-[2-[[2-(2-エトキシフェノキシ)エチル]アミノ]プロピル]ベンゼンスルホンアミド·塩酸塩 Usage And Synthesis
化学的特性White to Off-White Solid
使用Tamsulosin hydrochloride is a specific ;1-adrenoceptor antagonist. Used in the treatment of benign prostatic hypertrophy.
使用Tamsulosin is a specific α1-adrenoceptor antagonist. Used in the treatment of benign prostatic hypertrophy.
臨床応用Treatment of benign prostatic hyperplasia
薬物相互作用Potentially hazardous interactions with other drugs
Anaesthetics: enhanced hypotensive effect.
Antidepressants: enhanced hypotensive effect with MAOIs.
Antifungals: concentration increased by ketoconazole.
Avanafil, vardenafil, sildenafil and tadalafil: enhanced hypotensive effect, avoid concomitant use.
Beta-blockers: enhanced hypotensive effect; increased risk of first dose hypotensive effect.
Calcium-channel blockers: enhanced hypotensive effect; increased risk of first dose hypotensive effect.
Diuretics: enhanced hypotensive effect; increased risk of first dose hypotensive effect.
Moxisylyte: possibly severe postural hypotension.
代謝Tamsulosin is metabolised slowly in the liver primarily by the cytochrome P450 isoenzymes CYP2D6 and CYP3A4; it is excreted mainly in the urine as metabolites and some unchanged drug
Tags:80223-99-0